Mapping the EORTC QLQ C-30 onto the EQ-5D instrument: the potential to estimate QALYs without generic preference data

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

The aim of this article is to map the European Organization for Research and Treatment of Cancer (EORTC) QLQ C-30 onto the EQ-5D measure to enable the estimation of health state values based on the EORTC QLQ C-30 data. The EORTC QLQ C-30 is of interest because it is the most commonly used instrument to measure the quality of life of cancer patients.

Regression analysis is used to establish the relationship between the two instruments. The performance of the model is assessed in terms of how well the responses to the EORTC QLQ C-30 predict the EQ-5D responses for a separate data set.

The results showed that the model explaining EQ-5D values predicted well. All of the actual values were within the 95% confidence intervals of the predicted values. More importantly, predicted difference in quality-adjusted life-years (QALYs) between the arms of the trial was almost identical to the actual difference.

There is potential to estimate EQ-5D values using responses to the disease-specific EORTC QLQ C-30 measure of quality of life. Such potential implies that in studies that do not include disease-specific measures, it might still be possible to estimate QALYs.

Original languageEnglish
Pages (from-to)167-171
Number of pages5
JournalValue in Health
Volume12
Issue number1
Early online date11 Jul 2008
DOIs
Publication statusPublished - Jan 2009

Keywords

  • quality adjusted life-years
  • quality of life
  • regression modeling
  • utility assessment
  • European-organization
  • clinical-trials
  • health
  • SF-6D
  • state

Cite this

@article{a41a325a057442efb6fbc0b71de12142,
title = "Mapping the EORTC QLQ C-30 onto the EQ-5D instrument: the potential to estimate QALYs without generic preference data",
abstract = "The aim of this article is to map the European Organization for Research and Treatment of Cancer (EORTC) QLQ C-30 onto the EQ-5D measure to enable the estimation of health state values based on the EORTC QLQ C-30 data. The EORTC QLQ C-30 is of interest because it is the most commonly used instrument to measure the quality of life of cancer patients.Regression analysis is used to establish the relationship between the two instruments. The performance of the model is assessed in terms of how well the responses to the EORTC QLQ C-30 predict the EQ-5D responses for a separate data set.The results showed that the model explaining EQ-5D values predicted well. All of the actual values were within the 95{\%} confidence intervals of the predicted values. More importantly, predicted difference in quality-adjusted life-years (QALYs) between the arms of the trial was almost identical to the actual difference.There is potential to estimate EQ-5D values using responses to the disease-specific EORTC QLQ C-30 measure of quality of life. Such potential implies that in studies that do not include disease-specific measures, it might still be possible to estimate QALYs.",
keywords = "quality adjusted life-years, quality of life, regression modeling, utility assessment, European-organization, clinical-trials, health, SF-6D, state",
author = "Lynda McKenzie and {van der Pol}, Marjon",
year = "2009",
month = "1",
doi = "10.1111/j.1524-4733.2008.00405.x",
language = "English",
volume = "12",
pages = "167--171",
journal = "Value in Health",
issn = "1098-3015",
publisher = "ACADEMIC PRESS INC ELSEVIER SCIENCE",
number = "1",

}

TY - JOUR

T1 - Mapping the EORTC QLQ C-30 onto the EQ-5D instrument

T2 - the potential to estimate QALYs without generic preference data

AU - McKenzie, Lynda

AU - van der Pol, Marjon

PY - 2009/1

Y1 - 2009/1

N2 - The aim of this article is to map the European Organization for Research and Treatment of Cancer (EORTC) QLQ C-30 onto the EQ-5D measure to enable the estimation of health state values based on the EORTC QLQ C-30 data. The EORTC QLQ C-30 is of interest because it is the most commonly used instrument to measure the quality of life of cancer patients.Regression analysis is used to establish the relationship between the two instruments. The performance of the model is assessed in terms of how well the responses to the EORTC QLQ C-30 predict the EQ-5D responses for a separate data set.The results showed that the model explaining EQ-5D values predicted well. All of the actual values were within the 95% confidence intervals of the predicted values. More importantly, predicted difference in quality-adjusted life-years (QALYs) between the arms of the trial was almost identical to the actual difference.There is potential to estimate EQ-5D values using responses to the disease-specific EORTC QLQ C-30 measure of quality of life. Such potential implies that in studies that do not include disease-specific measures, it might still be possible to estimate QALYs.

AB - The aim of this article is to map the European Organization for Research and Treatment of Cancer (EORTC) QLQ C-30 onto the EQ-5D measure to enable the estimation of health state values based on the EORTC QLQ C-30 data. The EORTC QLQ C-30 is of interest because it is the most commonly used instrument to measure the quality of life of cancer patients.Regression analysis is used to establish the relationship between the two instruments. The performance of the model is assessed in terms of how well the responses to the EORTC QLQ C-30 predict the EQ-5D responses for a separate data set.The results showed that the model explaining EQ-5D values predicted well. All of the actual values were within the 95% confidence intervals of the predicted values. More importantly, predicted difference in quality-adjusted life-years (QALYs) between the arms of the trial was almost identical to the actual difference.There is potential to estimate EQ-5D values using responses to the disease-specific EORTC QLQ C-30 measure of quality of life. Such potential implies that in studies that do not include disease-specific measures, it might still be possible to estimate QALYs.

KW - quality adjusted life-years

KW - quality of life

KW - regression modeling

KW - utility assessment

KW - European-organization

KW - clinical-trials

KW - health

KW - SF-6D

KW - state

U2 - 10.1111/j.1524-4733.2008.00405.x

DO - 10.1111/j.1524-4733.2008.00405.x

M3 - Article

VL - 12

SP - 167

EP - 171

JO - Value in Health

JF - Value in Health

SN - 1098-3015

IS - 1

ER -